AbbVie, Inc.(NYSE : ABBV)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||1.24%||165.22||0.7%||$1347.13m|
|LLY||Eli Lilly & Co.||1.47%||326.29||1.1%||$1083.43m|
|BMY||Bristol-Myers Squibb Co.||1.28%||71.43||1.0%||$782.53m|
|MRK||Merck & Co., Inc.||1.03%||88.45||0.7%||$717.67m|
|ALNY||Alnylam Pharmaceuticals, Inc.||1.33%||199.41||8.2%||$220.28m|
|GBT||Global Blood Therapeutics, Inc.||-0.01%||68.48||5.4%||$191.16m|
|IDXX||IDEXX Laboratories, Inc.||3.69%||349.11||3.9%||$191.09m|
|HZNP||Horizon Therapeutics Plc||2.86%||66.10||5.4%||$178.62m|
|ATXI||Avenue Therapeutics, Inc.||26.50%||14.56||0.0%||$176.22m|
|SRPT||Sarepta Therapeutics, Inc.||1.72%||111.83||12.4%||$139.09m|
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.